Search results for

The specialized swabs required for coronavirus tests are quite different from your standard Q-tips. And U.S. hospitals are running out of them, creating another delay in efforts to expand testing.

Should "potential exposure" by a health worker to someone with coronavirus be enough to send that worker home for two weeks of self-quarantine? Health systems have begun debating relative risks.

As the partial closure of the government continues, here's a look at the affected programs that have a bearing on health and health care.

Molecular diagnostics are at the frontier of medical science. But along with precise information about health, the tests raise billing questions that can create a minefield for patients.

Inspectors are citing facilities more often than during the Obama administration. But in response to industry prodding, the average fine is nearly a third lower, and the total assessed is down.

The government used a 2009 financial stimulus package to move the country from paper medical charts to electronic records. Care was supposed to get better, safer and cheaper. It hasn't worked out.

Surprise billing is one of the rare public policy issues that are both bipartisan and in need of a federal solution. A hearing on Capitol Hill looked to insurers and providers to help figure it out.

A public hospital in Los Angeles gets over 1,000 unidentified patients a year. Most are quickly ID'd, but some require considerable gumshoe work — a task often complicated by medical privacy laws.

Critics question claims by federal officials that CanaRX jeopardizes patient safety. Many U.S. companies, cities, counties and school districts rely on the firm to help employees get cheaper medicine.

As recent arrivals to the U.S. are released from detention with health problems ranging from diarrhea to gaping wounds, doctors who are trying to help, with little federal support, feel the strain.